XML 128 R109.htm IDEA: XBRL DOCUMENT v3.24.1
Summary of Stock Option Activity (Details) - $ / shares
12 Months Ended
Jun. 30, 2023
Feb. 28, 2023
Nov. 22, 2022
Mar. 18, 2022
Dec. 31, 2023
Dec. 31, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]            
Number of Shares, Granted 42,635 38,026 232,816 4,343,017    
Weighted Average Exercise Price, Granted       $ 8.82    
Weighted Average Remaining Contractual Life (in Years), exercisable at Ending balance         5 years 3 months 10 days  
2022 Plan [Member]            
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]            
Number of Shares Common stock options, outstanding at Beginning balance         6,199,521  
Weighted Average Exercise Price, outstanding at Beginning balance         $ 15.26  
Weighted Average Remaining Contractual Life (in Years), outstanding at Beginning balance         4 years 5 months 4 days 8 years 2 months 12 days
Number of Shares, Granted         287,993  
Weighted Average Exercise Price, Granted         $ 4.22  
Number of Shares, Exercised         (6,927)  
Weighted Average Exercise Price, Exercised         $ 8.82  
Number of Shares, Forfeited         (449,333)  
Weighted Average Exercise Price, Forfeited         $ 9.70  
Number of Shares, Expired         (579,286)  
Weighted Average Exercise Price, Expired         $ 9.38  
Number of Shares Common stock options, outstanding at Ending balance         5,451,968 6,199,521
Weighted Average Exercise Price, outstanding at Ending balance         $ 9.56 $ 15.26
Number of Shares Common stock options, exercisable at Ending balance         4,049,393  
Weighted Average Exercise Price, exercisable at Ending balance         $ 9.64  
Weighted Average Remaining Contractual Life (in Years), exercisable at Ending balance         5 years 21 days  
Number of Shares Common stock options, not vested at Ending balance         1,402,575  
Number of Shares Common stock options, available for future grants at Ending balance [1]         542,847  
[1] Common stock available for future issuance under the 2022 Plan represent 1,800,000 of authorized shares; less 1,066,597 common stock options outstanding and 190,556 restricted stock units outstanding.